MAPK1 and neoplasm: The observed increase in EGFR and its downstream effectors p-AKT and ERK2 is consistent with the recognized role of EGFR signaling in promoting tumor growth, proliferation, and survival through activation of the PI3K/AKT and MAPK/ERK pathways [65].